A CFTR mRNA isoform for the treatment of 3’ CFTR PTC variants with Normand Allaire

In this episode, Dr. Paloma Giangrande, Editor-in-Chief of Molecular Therapy Nucleic Acids, speaks with Normand Allaire, Head of Genomics at the Cystic Fibrosis Foundation Therapeutics Lab. They discuss the article, Upregulation of a CFTR mRNA isoform has therapeutic potential for the treatment of 3’ CFTR PTC variants, which introduces an ASO-based therapeutic approach to cystic fibrosis for the 10% of patients who lack an approved treatment. Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au (https://www.scottbuckley.com.au/) Show your support for ASGCT!: https://asgct.org/membership/donate See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.